Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Establish the Ability of the Chembio Diagnostics Systems, Inc. DPP HIV 1/2 Rapid Test to Qualitatively Detect the Presence of Antibodies Against HIV-1 in Oral Fluid, Whole Blood (Capillary and Venous), Serum and Plasma

NCT01032902 is registered in ClinicalTrials.gov with Chembio Diagnostic Systems, Inc. as lead sponsor.

NCT NCT01032902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01032902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Establish the Ability of the Chembio Diagnostics Systems, Inc. DPP HIV 1/2 Rapid Test to Qualitatively Detect the Presence of Antibodies Against HIV-1 in Oral Fluid, Whole Blood (Capillary and Venous), Serum and Plasma
Lead sponsor
Chembio Diagnostic Systems, Inc.
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
April 30, 2012
Enrollment
2,808 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections